EMEA-001487-PIP01-13 - paediatric investigation plan

Gevokizumab
PIPHuman

Key facts

Active Substance
Gevokizumab
Therapeutic area
Ophthalmology
Decision number
P/0148/2014
PIP number
EMEA-001487-PIP01-13
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of chronic non-infectious uveitis
Route(s) of administration
Subcutaneous use
Contact for public enquiries

Les Laboratoires SERVIER

France
E-mail: cafaro@xoma.com
Tel. +1 5105415034
Fax +1 5102952724

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Decision date

Decision

Share this page